Health Economics Review

2011 - 2026

Current editor(s): J. Matthias Graf von der Schulenburg

From Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

Access Statistics for this journal.
Is something missing from the series or not right? See the RePEc data check for the archive and series.

Volume 16, issue 1, 2026

The economic burden of diabetes-related visual impairment and blindness in Saudi Arabia pp. 1-10

Gihan Hamdy Elsisi, Abdullah Alhumaidan, Abdulrahman Alturaiki, Hana Abdul Kareem, Nada Abu-Shraie, Ramzi Al Judaibi and Saleh Alshehri

Cost analysis of financial, productivity, and informal care burdens in families raising children with congenital anomalies pp. 1-10

Evelina Marija Vaitėnienė, Audronė Jakaitienė, Liubovė Murauskienė and Algirdas Utkus

Beyond average costs: large-scale evidence on DRG payment reform and the distribution of standardized inpatient spending in China pp. 1-10

Zhuang Cao, Yifan Yao, Bin Cui, Jian Wang and Changli Jia

Harnessing oil revenues for sustainable development: evaluating Brazil’s “royalties’ law” and its impact on healthcare pp. 1-22

Rômulo E. de A. Rodrigues, Wallace P. S. de Farias Souza and Jevuks Araujo

Burden or benefit? Unveiling the impact of out-of-pocket health expenditures in Somalia’s healthcare system pp. 1-15

Khalid Mohamed Mohamud, Said Yusuf Warei and Ali Hajji Adam Abubakr

Beyond seed funding: why Nigerian digital health startups struggle to grow pp. 1-15

Ubalaeze Solomon Elechi, Chibuzo Okechukwu Onah, Mohamed Albert Tarawallie and Ironuru Ifeanyi

Assessing the impact of government healthcare expenditure and life expectancy on economic growth in Saudi Arabia: an econometric time-series study (2000–2023) pp. 1-15

Razan Alghannam and Abeer Alharbi

Paying for hospital care in seven central and Eastern European countries – a comparative analysis pp. 1-15

Katarzyna Dubas-Jakóbczyk, Krisztina Davidovics, Antoniya Dimova, Triin Habicht, Pavel Hroboň, Laszlo Imre, Kaija Kasekamp, Mincho Minev, Liubove Murauskienė, Martin Smatana, Gyoergy Rethazi, Angelika Szalayova, Artur Szetela, Lenka Šlegerová and Roman Topór-Mądry

Health insurance coverages and demand for modern contraceptive choices among reproductive-age women in Thailand pp. 1-15

Nattanon Phonkacha and Piriya Pholphirul

Technical efficiency of sub-district level hospitals in Bangladesh: a comparative frontier analysis pp. 1-15

Md. Zahid Hasan, Edward JD Webb, Silviya Nikolova, Khadija Islam Tisha, Zahidul Quayyum and Tim Ensor

The global economic burden of schizophrenia: an umbrella review of systematic reviews and meta-analyses with reconstructed primary-study cost data pp. 1-15

Attila Imre, Ágota Mészáros, Bertalan Németh, Balázs Nagy, Judit Józwiak-Hagymásy, Giacomo Cecere, Philipp Homan, Iris E. C. Sommer and Balázs Babarczy

Understanding recent dynamics: prosperity and longevity in Ghana pp. 1-18

Ussif Abdul-Aziz Sirin, Reiner Anafo, Edward Ebo Onumah, Jamal Mohammed and Ramatu Ussif

Can the remuneration scheme of general practitioners affect their antibiotic prescription behaviour? pp. 1-18

Yana V. Zykova, Eivor H. Hoff, Kristian B. Kraft, Arnstein Mykletun and Kristian A. Østby

Efficiency of health systems in developing countries: the case of West African countries pp. 1-12

Kossivi Akoetey and Anne Viallefont

Community-based care services and outpatient utilization among older adults: evidence from urban China pp. 1-12

Shuaizhen Chen, Fengyi Sun, Zhan Zhao and Jialong Tan

Point-of-care core needle biopsy pathway for early diagnosis of lymph node masses: comparative costing of a scalable pathway pp. 1-12

David Richardson, Waarisa Fareed-Brey, Katherine Antel, Karryn Brown, Jenna Bailey, Estelle Verburgh and Lucy Cunnama

Cost-effectiveness of zanubrutinib versus ibrutinib in the first-line treatment for patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in China pp. 1-12

Ying Liu, Wei Li, Xiaoxia Wei, Haijing Guan and Sheng Han

A systematic review on indirect costs related to loss of productivity after stroke pp. 1-12

Adrián Martín-Gutiérrez, Luis Leal-Vega, María Begoña Coco-Martín, Verónica Olmedo-Vega and Juan F. Arenillas-Lara

Economic evaluation of direct oral anticoagulants (DOACs) for venous thromboembolism with different etiologies: a systematic review pp. 1-12

Fereshte Karimi, Soheila Rajaie, Samad Azari, Mohammad Saeid Abbaszadeh and Zeinab Karimi

Health economic analysis of organizational models for breast cancer surgery: a bottom-up micro-costing and cost-minimization approach pp. 1-12

Johan Eriksson, Kaspar Walter Meili, Lena Lindholm, Micael Appelblad and Malin Sund

Economic evaluation of national immunization program vaccines in China: a systematic review pp. 1-12

Jiannan Sun, Xu Jin, Haofei Li, Lan Zhou, Ling Jie Cheng, Runhong Li, Jiaxuan Shi, Yiyin Cao, Jinmei Li, Xiuzhi Cai, Tiemin Zhai and Weidong Huang

Economic burden and cost of non-adherence in type 2 diabetes: a systematic review of middle- and high-income countries pp. 1-12

Piedad Gómez-Torres, Isabel Rosario Blázquez-Ornat, María Luisa Lozano Del Hoyo, Ma. Esther Samaniego-Díaz de Corcuera, Emilia Ferrer-López, Enrique Ramón-Arbués, Sofía Pilar Pérez-Calahorra, Manuel Gómez-Barrera and Maria Teresa Fernández-Rodrigo

Comparative cost-effectiveness analysis of different treatment strategies for distal radius fracture pp. 1-12

Haiyu Xu, Youhui Lin, Zihao Liu, Liying Zhao and Wei Cheng

The feasibility of social impact bonds in financing tertiary health care quality: qualitative stakeholders’ perspectives in Kenya pp. 1-13

Ezekiel Karino, James Ndegwa and Vincent Were

Smokers’ willingness to pay for smoking cessation services and its determinants: evidence from China pp. 1-13

Jia Li, Yixin Zhao, Kexin Peng, Jiushun Zhou and Lian Yang

Health economics evaluation of artificial intelligence in the field of oncology: a scoping review pp. 1-13

Hein Minn Tun, Hanif Abdul Rahman, Lin Naing and Owais Ahmed Malik

Medical care cost dynamics during COVID-19 pandemic: financial implications for Japanese health insurance system pp. 1-13

Yuji Hiramatsu, Yuji Frui and Hiroo Ide

Selecting risk adjusters with penalized regression and expert judgment: evidence from Colombia pp. 1-30

Camilo Arias

Can AI write your code? A case study of chatgpt’s statistical coding capabilities for quantitative research pp. 1-8

Debra Winberg, Ethan Tsai, Tiange Tang, Dennis Xuan, Nicolas Marchi and Lizheng Shi

Factors associated with breast cancer screening among insured and uninsured women in Tanzania: an analysis of the Tanzania demographic and health survey 2022 pp. 1-8

Amani Anaeli, Pankras Luoga, Tumaini Nyamhanga and Malale Tungu

Overview of the Japanese Rapid Introduction Premium as a drug pricing framework to enhance patient access to innovative drugs pp. 1-7

Kento Takamura, Gai Jinnai, Yuki Niwa and Masuo Kondoh

Financial burden of noncommunicable diseases on households in Bangladesh: a quasi-experimental analysis using national survey data pp. 1-19

Taslima Rahman, Dominic Gasbarro and Khurshid Alam

Protecting healthcare workers? Effects of a multilevel intervention targeting emotional demands pp. 1-19

Louise Schubert Paaske, Nicolai Simonsen Damslund, Ida Elisabeth Huitfeldt Madsen, Sofie Østergaard Jaspers and Line Planck Kongstad

Does price disclosure promote competition in private MRI markets? A difference-in-differences analysis pp. 1-23

Riina Hiltunen

Environmental regulation and industrial restructuring: choices of health industry enterprises in China pp. 1-23

Yao Yao, Yujie Cui and Gordon Liu

Catastrophic and impoverishing health expenditures in fragmented public health systems: lessons from Mexico, 2000–2022 pp. 1-17

Diego Cerecero-García, Octavio Gómez-Dantés, Thomas Hone, Carlos Pineda-Antúnez, Alejandro Mohar-Betancourt, Laura Flamand and Edson Serván-Mori

A systematic review of economic evaluations of community-based healthcare interventions for neurodisability management pp. 1-17

Áine J. Gorman, Ann Kirby, Peter Cleary, Mari O’Connor and Aileen Murphy

Health shocks and labour market outcomes: evidence from The Irish Longitudinal Study on Ageing (TILDA) pp. 1-17

Likun Mao and Charles Normand

Micro-costing of genetic and genomic testing in oncology: a systematic review of laboratory resources and costs pp. 1-17

Sook Pin Goh, Jue Ern Chan and Siew Chin Ong

Cost–benefit analysis of pre-entry tuberculosis screening for incoming migrants to Japan: a focus on Nepalese migrants pp. 1-14

Yoko Iwaki, Takayuki Hayashi, Shuhei Nomura, Shoko Shimamura, Rohita Gauchan and Michael C. Huang

Effects of housing demolition on health and medical utilization: evidence from China pp. 1-14

Di Yang and Yubraj Acharya

The complex price setting and reimbursement of non-industrial advanced therapy medicinal products pp. 1-14

Zuzana Špacírová, Juan Carlos Rejon-Parrilla and Jaime Espín

Developing shortcut algorithms for value-based pricing of pharmaceuticals pp. 1-14

Afschin Gandjour

Pay attention to your social capital! It determines your health: an analysis for the elderly in Europe pp. 1-16

Javier Lera, David Cantarero-Prieto and Sara Pinillos-Franco

The economic burden of mental health deterioration on Australian households: a longitudinal analysis of out-of-pocket healthcare expenditures pp. 1-16

Md Ehsanul Haque Tamal, Kamrul Hassan, Dominic Gasbarro and Khurshid Alam

Systematic review of health economic evaluation of robot-assisted hip and knee arthroplasty pp. 1-9

Yajing Gao, Yi Yang, Zhuofu Li, Bai Zang, Chengfengyi Yang, Feifei Zhou and Qiaoqin Wan

Cost-utility analysis of eptinezumab for migraine prevention in Taiwan pp. 1-9

Cheng-Shen Chan, Tzu-Yao Huang, Wei-Hsuan Tseng, Tsung-Kun Lin, Fu-Chi Yang, Yi Liu, Yuan-Zhen Ruan and Ping-Hsuan Hsieh

An economic analysis of the impact of education on health behaviours and health outcomes in South Africa: a case of Amathole District Municipality and Buffalo City Metropolitan Municipality pp. 1-9

Besuthu Hlafa, Asrat Tsegaye, Matt Dickson and Dumisani Macdonald Hompashe

All-in-one spinal cord stimulation and its economic impact pp. 1-9

José Emilio LLopis Calatayud, Mónica Ocón, Pablo Evaristo Bretos-Azcona and Desire Rodriguez Bezos

Value of information analyses for advanced cell therapies: a systematic review pp. 1-9

Alexander Heaps and Sean P. Gavan

Economics of diagnosis of disabilities among adults and children: evidence from Russia pp. 1-9

Artyom Jelnov and Maria Yuzefov

Productivity costs of type 2 diabetes with or without co-occurring substance use disorder and depression pp. 1-11

Olli Kurkela, Saara Metso, Leena Forma, Kimmo Suokas, Pekka Rissanen and Jaakko Nevalainen

Cost of chemotherapy-related care for breast cancer care: evidence and implications from a provider perspective at a public tertiary hospital in South Africa pp. 1-11

Ck Oladayo, M. Sibanda, L. Makhele and M. Matlala

The economic burden of maternal mortality: a scoping review pp. 1-11

Angela Nana Esi Ackon, Alberta Ama Atta Ackon, Thomas Abugbilla Atugba and Livingstone Asem

Cost-benefit potential of sperm function testing to the treatment pathway for unexplained infertility: a modelling study from the UK NHS perspective pp. 1-11

Shen Chuen Khaw, Jonathan SY Lee, Huang Lin Khaw, Christopher LR Barratt and Sarah Martins da Silva

The economic impact of retinal diseases for which gene therapy is emerging: a systematic literature review pp. 1-21

Claire Willmington, Ann Kirby and Aileen Murphy

Estimating the causal effect of cardiometabolic conditions on socioeconomic and healthcare outcomes: a scoping review of Mendelian randomization studies pp. 1-21

Sara Pedron, Xiao Tan, Juliane Maushagen, Anna-Janina Stephan, Jacob Burns, Eleanor Sanderson, Kaitlin Wade and Michael Laxy